Logo image of BBIO

BRIDGEBIO PHARMA INC (BBIO) Stock Analyst Ratings

NASDAQ:BBIO - Nasdaq - US10806X1028 - Common Stock - Currency: USD

36.85  +0.05 (+0.12%)

After market: 36.85 0 (0%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to BBIO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 52.57. This target is 42.66% above the current price.
BBIO was analyzed by 22 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BBIO.
In the previous month the buy percentage consensus was at a similar level.
BBIO was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
BBIO Historical Analyst RatingsBBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -66 -60 -54 -48 -42 -36 -30 -24 -18 -12 -6 0 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 36.8540.4049.9852.5773.50 - 9.63% 35.63% 42.66% 99.46%
BBIO Current Analyst RatingBBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-02-21 Cantor Fitzgerald Reiterate Overweight -> Overweight
2025-02-21 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2025-02-21 Citigroup Maintains Buy -> Buy
2025-02-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-12 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-12-23 Evercore ISI Group Maintains Outperform -> Outperform
2024-12-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-25 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-11-25 B of A Securities Maintains Buy -> Buy
2024-11-25 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-15 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-10-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-17 Leerink Partners Maintains Outperform -> Outperform
2024-10-16 ScotiaBank Initiate Sector Outperform
2024-10-03 Oppenheimer Initiate Perform
2024-10-02 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-30 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-16 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-11 B of A Securities Maintains Buy -> Buy
2024-09-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-09-04 Piper Sandler Initiate Overweight
2024-09-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-27 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-22 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-07 Evercore ISI Group Maintains Outperform -> Outperform
2024-08-07 JP Morgan Maintains Overweight -> Overweight
2024-08-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-01 Cantor Fitzgerald Reiterate Overweight -> Overweight